A bioinformatics approach for identification of miR-100 targets implicated in breast cancer

R Shamsi1, M Seifi-Alan1, A Behmanesh2

  • 1Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Insights

Researchers identified novel microRNA-100 (miR-100) target genes in breast cancer using computational predictions and gene expression data. This discovery aids in understanding breast cancer pathogenesis and developing new therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs regulating protein expression and implicated in tumorigenesis.
  • miR-100 exhibits context-dependent tumor suppressor or oncogenic functions in various cancers, including breast cancer.
  • miR-100 influences key processes in breast cancer such as apoptosis and epithelial-mesenchymal transition.

Purpose of the Study:

  • To introduce a novel approach for identifying miR-100 target genes potentially involved in breast cancer pathogenesis.
  • To combine computational predictions with gene expression data for robust target identification.

Main Methods:

  • Utilized 14 online miRNA target prediction tools.
  • Analyzed gene expression data obtained from DNA microarray technology.
  • Integrated predicted targets with experimental gene expression data to identify high-confidence miR-100 targets.

Main Results:

  • Proposed a list of miR-100 target genes implicated in breast cancer development.
  • Demonstrated a combined approach for accurate miRNA target identification.

Conclusions:

  • miR-100 is a significant regulator in breast cancer, with context-dependent roles.
  • Identification of miR-100 targets provides a foundation for novel breast cancer treatment strategies.
  • These findings may lead to new therapeutic modalities or enhance existing cancer treatments.